Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 1999, p. 3205-3215, Vol. 19, No. 4
Cancer Biology Program,
Received 29 May 1998/Returned for modification 16 July
1998/Accepted 14 January 1999
The nontransmembrane protein tyrosine phosphatase SHP-2 plays a
critical role in growth factor and cytokine signaling pathways. Previous studies revealed that a fraction of SHP-2 moves to focal contacts upon integrin engagement and that SHP-2 binds to SHP substrate
1 (SHPS-1)/SIRP-1
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Regulation of Early Events in Integrin Signaling by
Protein Tyrosine Phosphatase SHP-2

, a transmembrane glycoprotein with adhesion
molecule characteristics (Y. Fujioka et al., Mol. Cell. Biol.
16:6887-6899, 1996; M. Tsuda et al., J. Biol. Chem. 273:13223-13229). Therefore, we asked whether SHP2-SHPS-1 complexes participate in
integrin signaling. SHPS-1 tyrosyl phosphorylation increased upon
plating of murine fibroblasts onto specific extracellular matrices.
Both in vitro and in vivo studies indicate that SHPS-1 tyrosyl
phosphorylation is catalyzed by Src family protein tyrosine kinases
(PTKs). Overexpression of SHPS-1 in 293 cells potentiated integrin-induced mitogen-activated protein kinase (MAPK) activation, and potentiation required functional SHP-2. To further explore the role
of SHP-2 in integrin signaling, we analyzed the responses of SHP-2 exon
3
/
and wild-type cell lines to being plated on
fibronectin. Integrin-induced activation of Src family PTKs, tyrosyl
phosphorylation of several focal adhesion proteins, MAPK activation,
and the ability to spread on fibronectin were defective in SHP-2 mutant
fibroblasts but were restored upon SHP-2 expression. Our data suggest a
positive-feedback model in which, upon integrin engagement, basal
levels of c-Src activity catalyze the tyrosyl phosphorylation of
SHPS-1, thereby recruiting SHP-2 to the plasma membrane, where, perhaps
by further activating Src PTKs, SHP-2 transduces positive signals for
downstream events such as MAPK activation and cell shape changes.
*
Corresponding author. Mailing address: Cancer Biology
Program, Division of Hematology-Oncology, Beth Israel Deaconess
Hospital and Harvard Medical School, Boston, MA 02215. Phone: (617)
667-4174. Fax: (617) 667-0610. E-mail for B.G.N.:
bneel{at}bidmc.harvard.edu. E-mail for S.M.T.:
sthomas{at}bidmc.harvard.edu.
Present address: Ariad Pharmaceuticals, Cambridge, MA 02139.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|